Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ExPEC4V in recurrent UTI
NCT02289794Phase 1Completed
- Sponsor
- GlycoVaxyn
- Start
- Jan 2014
- Primary completion
- Jul 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in urinary tract infection (UTI) comparing ExPEC4V with Placebo (2 arms). Primary endpoint: Number of subjects experiencing an adverse events at 30 days. Started Jan 2014; status: completed.
02
Drugs
ExPEC4V
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT02289794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289794.